Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced a new placement or other type of issue involving the proposed issuance of 719,424 ordinary fully paid securities, scheduled for the 4th of July, 2024. This move by the biotechnology firm aims to expand its financial capabilities, pending ASX approval for quotations of the new securities.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
